Investigating the effects of PFAS exposure in mothers and infants.
Official title: Assessment of Early Life PFAS Exposure in Perinatal Biospecimens, Infant Formula, and Breastmilk.
Funded at University of Michigan at Ann Arbor · NIH-10917348 · Data updated 2026-11-12
This study is looking at how certain chemicals called PFAS, which can be found in things like breastmilk and baby formula, might affect the health of babies during pregnancy and infancy, especially in relation to issues like low birth weight and other health changes.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $158,895 |
| NIH project number | 5K01ES035398-02 |
| Project ID | NIH-10917348 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include pregnant women and new mothers who are concerned about chemical exposures and their potential effects on their infants.
✕Less likely to help
Patients who are not pregnant or do not have infants may not receive direct benefits from this research.
What this research studies
This research focuses on understanding how exposure to per- and polyfluorinated alkyl substances (PFAS) during pregnancy and infancy affects health outcomes. By analyzing biospecimens from mothers and infants, including breastmilk and infant formula, the study aims to quantify levels of both legacy and newer PFAS compounds. The research employs advanced analytical methods to assess the relationship between these chemicals and various health issues, such as low birth weight and metabolic changes. This investigation is crucial for identifying potential risks associated with PFAS exposure in early life.
Why it matters
Potential benefit: If successful, this research could lead to improved guidelines for reducing PFAS exposure in pregnant women and infants, ultimately enhancing child health outcomes.
How similar studies have gone: Previous research has indicated significant health risks associated with PFAS exposure, suggesting that this investigation could build on established findings and contribute valuable new insights.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Manz, Katherine Elizabeth — University of Michigan at Ann Arbor
- Study coordinator: Manz, Katherine Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.